Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.

Abstract

The intracellular calcium level is increased during ischemia and early reperfusion. The aim of this study was to study the role of the calcium influx in the development of myocardial ischemic and reperfusion injury during the early and late phases of ischemia and during early reperfusion. An ultrashort-acting calcium antagonist, clevidipine, was used as a tool for this investigation. Pentobarbital-anesthetized pigs were subjected to 45 minutes of LAD occlusion followed by 240 minutes of reperfusion. In the first set of experiments, clevidipine (0.3 nmol/kg per minute) was infused over 5 minutes into the ischemic myocardium via a catheter in the LAD, starting at 5, 35, or 44 minutes following the onset of ischemia (n = 6 in each group). The area at risk and the infarct size were determined after 240 minutes of reperfusion by staining with Evans blue dye and triphenyl tetrazolium chloride (TTC), respectively. In a second set of experiments, two groups of animals (n = 6 in each) were subjected to the same periods of ischemia and reperfusion; one group received no infusion during ischemia, whereas the other group received vehicle infusion during a 5-minute period between 5 and 10 minutes of ischemia. In the first set of experiments, there were no significant differences between the groups with regard to hemodynamic variables. The area at risk expressed as a percentage of the left ventricle was of similar magnitude in all three clevidipine-treated groups (about 18%). The infarct size, expressed as a percentage of the area at risk, was significantly smaller in pigs given clevidipine after 5 minutes (58 +/- 17%; p < 0.01) and after 44 minutes (42 +/- 6%; p < 0.01) of ischemia than in pigs receiving clevidipine after 35 minutes of ischemia (85 +/- 4%). The difference in infarct size between pigs given clevidipine after 5 or 44 minutes of ischemia was not significant. In the second set of experiments, there was a similar area at risk and no significant difference in infarct size between the noninfusion group and the 5-minute vehicle infusion group, indicating that the LAD infusion per se did not affect infarct size. The present results demonstrate that blockade of calcium influx by the short-acting dihydropyridine calcium antagonist clevidipine during the early phase of ischemia and at the time of reperfusion, but not during a late phase of ischemia, limits infarct size induced by ischemia and reperfusion. This indicates that the pathophysiological importance of calcium influx varies according to the different phases of myocardial ischemia and reperfusion.

• Authors: Daisuke Segawa, Per-Ove Sjöquist, Qing-Dong Wang, Adrian Gonon, Lars Rydén
• Journal: Journal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 40 Issue 3 Pg. 339-45 (Sep 2002) ISSN: 0160-2446 [Print] United States
• PMID: 12198319 (Publication Type: Journal Article)

Chemical References

• Cardiotonic Agents
• Pyridines
• clevidipine
• Calcium

Topics

• Animals
• Calcium (antagonists & inhibitors, metabolism)
• Cardiotonic Agents (pharmacology, therapeutic use)
• Coronary Circulation (drug effects)
• Female
• Hemodynamics (drug effects)
• Male
• Myocardial Infarction (drug therapy, metabolism)
• Myocardial Ischemia (drug therapy, metabolism)
• Myocardial Reperfusion Injury (drug therapy, metabolism)
• Pyridines (pharmacology, therapeutic use)
• Swine
• Time Factors
• Ventricular Fibrillation (physiopathology)